• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients.

作者信息

Glaholm J, Bloom H J, Crow J H

机构信息

Royal Marsden Hospital, Department of Radiotherapy and Oncology, Sutton, Surrey, England.

出版信息

Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):755-61. doi: 10.1016/0360-3016(90)90394-y.

DOI:10.1016/0360-3016(90)90394-y
PMID:2108937
Abstract

One hundred and eighty-six patients with intracranial meningiomas were treated at the Royal Marsden Hospital between 1963 and 1983 with megavoltage photon irradiation (60Co gamma rays and 6-8 Mv. X rays). Survival parameters were measured from the time of referral for radiotherapy. The 10-year actuarial cause-specific survival was 67% for all cases and the actuarial disease-free survival was 61%. Both malignant and also "aggressive benign" histologies were associated with poor long-term survival. Benign angioblastic meningioma was associated with lower actuarial cause specific and disease-free survival compared with other benign histological sub-groups. Prognosis was related to the extent of initial surgical resection. Of those who underwent subtotal or partial tumor resection with post-operative radiotherapy the 10-year actuarial cause-specific survival was 77%, and in inoperable patients treated by radiotherapy alone it was 46%. Radiotherapy alone resulted in improvement of neurological performance (Karnofsky) in 12 out of the 32 (38%) patients with inoperable disease. The 10-year survival of patients referred for irradiation following "complete" surgical resection was only 34% owing to the high incidence of adverse histological sub-types in this treatment sub-group. Based upon univariate analysis, performance status of less than 60 (Karnofsky) and also age greater than 50 years at the time of referral for radiotherapy were adverse prognostic factors. Multivariate analysis revealed that histological type, extent of surgical resection and performance status at the time of presentation for radiotherapy were independent prognostic variables. However age at the time of referral lost significance as an independent variable when analyzed using this method. Patients undergoing complete surgical resection for the typical benign non-aggressive meningioma do not require adjuvant irradiation. The results of this study support the role of radiotherapy for treatment of incompletely resected and inoperable meningioma of all 3 histological types (benign, "aggressive benign", malignant).

摘要

相似文献

1
The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients.
Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):755-61. doi: 10.1016/0360-3016(90)90394-y.
2
Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.恶性脑膜瘤:初始积极手术及辅助放疗的指征。
J Neurooncol. 1998 Apr;37(2):177-88. doi: 10.1023/a:1005853720926.
3
Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.确定辅助放疗在脑膜瘤治疗中的作用:一项监测、流行病学和最终结果分析。
Neurosurg Focus. 2019 Jun 1;46(6):E3. doi: 10.3171/2019.3.FOCUS1971.
4
Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.非典型性和恶性脑膜瘤:68 例放疗患者的结局和预后因素。
J Neurooncol. 2013 Dec;115(3):421-7. doi: 10.1007/s11060-013-1239-7. Epub 2013 Sep 18.
5
Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.非典型和恶性脑膜瘤的管理:大剂量三维适形放射治疗的作用
J Neurooncol. 2000 Jun;48(2):151-60. doi: 10.1023/a:1006434124794.
6
Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990.次全切除脑膜瘤术后放疗。对1967年至1990年期间接受治疗的140例患者的回顾性分析。
J Neurosurg. 1994 Feb;80(2):195-201. doi: 10.3171/jns.1994.80.2.0195.
7
Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.良性脑膜瘤:接受质子和光子联合放射治疗的部分切除、活检及复发性颅内肿瘤。
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1363-70. doi: 10.1016/s0360-3016(00)01411-5.
8
Radiotherapy after surgery for benign cerebral meningioma.良性脑脑膜瘤术后放疗。
Radiother Oncol. 2004 Apr;71(1):85-90. doi: 10.1016/j.radonc.2004.01.006.
9
[Radiotherapy for intracranial meningioma: special reference to malignant and high risk benign meningioma].[颅内脑膜瘤的放射治疗:特别提及恶性和高危良性脑膜瘤]
Nihon Igaku Hoshasen Gakkai Zasshi. 1995 Dec;55(15):1047-52.
10
Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.侵袭性脑膜瘤的临床病理特征,强调放射治疗在治疗中的作用。
Strahlenther Onkol. 2006 Nov;182(11):641-6. doi: 10.1007/s00066-006-1555-3.

引用本文的文献

1
Radiotherapy for meningiomas.脑膜瘤的放射治疗。
J Neurooncol. 2022 Nov;160(2):505-515. doi: 10.1007/s11060-022-04171-9. Epub 2022 Oct 31.
2
A Probability-Based Investigation on the Setup Robustness of Pencil-beam Proton Radiation Therapy for Skull-Base Meningioma.基于概率的颅底脑膜瘤笔形束质子放射治疗设置稳健性研究
Int J Part Ther. 2021 Jan 28;7(3):34-45. doi: 10.14338/IJPT-20-00009.1. eCollection 2021 Winter.
3
Recent advances in managing/understanding meningioma.脑膜瘤管理/认识方面的最新进展
F1000Res. 2018 Apr 24;7. doi: 10.12688/f1000research.13674.1. eCollection 2018.
4
Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.立体定向放射治疗作为颅内二级和三级脑膜瘤的原发确定性或术后治疗,比复发性脑膜瘤的立体定向放射治疗更能控制疾病。
J Neurooncol. 2017 Sep;134(2):407-416. doi: 10.1007/s11060-017-2540-7. Epub 2017 Jun 30.
5
Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.非典型或间变性脑膜瘤复发的治疗反应和生存结果的预测因素。
Neurosurgery. 2018 Jun 1;82(6):824-832. doi: 10.1093/neuros/nyx312.
6
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.脑膜瘤:知识库、治疗结果及不确定性。RANO综述。
J Neurosurg. 2015 Jan;122(1):4-23. doi: 10.3171/2014.7.JNS131644.
7
Efficacy of postoperative radiotherapy for high grade meningiomas.高级别脑膜瘤术后放疗的疗效
J Neurooncol. 2014 Sep;119(2):405-12. doi: 10.1007/s11060-014-1507-1. Epub 2014 Jun 26.
8
Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma.基于直线加速器的立体定向放射治疗和放射外科治疗在脑膜瘤患者中的应用。
Radiat Oncol. 2014 Mar 20;9:78. doi: 10.1186/1748-717X-9-78.
9
Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas.比较采用固定束或离子回旋加速器的强度调制放射治疗(IMRT)与强度调制粒子治疗(IMPT)治疗颅底脑膜瘤患者的效果。
Radiat Oncol. 2012 Mar 22;7:44. doi: 10.1186/1748-717X-7-44.
10
Impaired survival and long-term neurological problems in benign meningioma.良性脑膜瘤患者的生存率降低和长期神经问题。
Neuro Oncol. 2012 May;14(5):658-66. doi: 10.1093/neuonc/nos013. Epub 2012 Mar 9.